PFE - Is There A Safer Way to Invest in a Coronavirus Vaccine?
The long-term solution to ending the coronavirus pandemic and returning to normal life is an effective vaccine. Companies and researchers across the globe have accepted the challenge of trying to develop one as quickly as possible. Investors expect the stocks of companies that successfully deliver a vaccine to gain in value.
According to BioCentury, a healthcare industry news publisher, 12 coronavirus vaccines are in human trials. Another 77 vaccine programs are in preclinical development. How can someone hoping to invest in a developer of a potential coronavirus vaccine figure out where to begin?
Image Source: Getty Images.